Aantal gebruikers 2015-2019 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 53 | 50 | 30 | 40 | 26 |
| J05AF02 Didanosine (Videx ®) | 60 | 42 | 32 | 2 | . |
| J05AF04 Stavudine | 3 | 3 | 3 | . | . |
| J05AF05 Lamivudine (Epivir ®) | 1.066 | 1.138 | 1.212 | 965 | 767 |
| J05AF06 Abacavir (Ziagen ®) | 318 | 303 | 294 | 267 | 233 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 2.147 | 2.349 | 2.504 | 2.322 | 2.246 |
| J05AF08 Adefovir (Hepsera ®) | 135 | 108 | 99 | 90 | 71 |
| J05AF09 Emtricitabine (Emtriva ®) | 59 | 67 | 51 | 38 | 34 |
| J05AF10 Entecavir (Baraclude ®) | 1.473 | 1.575 | 1.747 | 1.918 | 2.053 |
| J05AF11 Telbivudine (Sebivo ®) | 8 | 5 | 6 | 6 | 7 |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | . | . | 59 | 202 | 415 |